Molecular therapy for bone cancer: 1α,25-dihydroxy vitamin D(3) inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via up regulation of its target gene, 25/December/2013, 7.59 am

Molecular therapy for bone cancer: 1α,25-dihydroxy vitamin D(3) inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via up regulation of its target gene, 25/December/2013, 7.59 am https://genomediscovery.org/wp-content/themes/fildisi/images/empty/thumbnail.jpg 150 150 https://genomediscovery.org/wp-content/themes/fildisi/images/empty/thumbnail.jpg December 25, 2013 December 25, 2013

Idea Proposed by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Molecular therapy for bone cancer: 1α,25-dihydroxy vitamin D(3) inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via up regulation of its target gene, 25/December/2013, 7.59 am,Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org